1290 Essex Small Cap Growth I holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
1290 Essex Small Cap Growth Fund Class I ESCJX
- NAV / 1-Day Return — / —
- Total Assets —
-
Adj. Expense Ratio
—
- Expense Ratio —
- Distribution Fee Level —
- Share Class Type —
- Category —
- Investment Style —
- Min. Initial Investment —
- Status
- TTM Yield —
- Turnover —
Morningstar’s Analysis ESCJX
Will ESCJX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Kiniksa Pharmaceuticals International PLC Class A | 2.74 | 3M | Healthcare |
Adaptive Biotechnologies Corp | 2.45 | 3M | Healthcare |
JPMorgan Prime Money Market IM | 2.33 | 3M | Cash and Equivalents |
CECO Environmental Corp | 2.24 | 3M | Industrials |
Travere Therapeutics Inc Ordinary Shares | 1.97 | 2M | Healthcare |
Leonardo DRS Inc | 1.96 | 2M | Industrials |
Oceaneering International Inc | 1.72 | 2M | Energy |
BrainsWay Ltd ADR | 1.72 | 2M | Healthcare |
Tower Semiconductor Ltd | 1.57 | 2M | Technology |
Lincoln Educational Services Corp | 1.52 | 2M | Consumer Defensive |